文献速递重症综合管理与镇静镇痛心脑血管急症

白藜芦醇改善脓毒症相关脑病大鼠认知功能障碍的机制

[Mechanism of resveratrol on ameliorating the cognitive dysfunction induced by sepsis associated encephalopathy in rats].
PubMed 文献 · Zhonghua Wei Zhong Bing Ji Jiu Yi Xue · 2020-01-01
一句话结论动物实验显示白藜芦醇通过抑制星形胶质细胞MMP-9、保护紧密连接蛋白,降低血脑屏障通透性,改善SAE大鼠认知功能。

该研究为动物实验,将12周龄雄性SD大鼠随机分为假手术组、脓毒症组和白藜芦醇组,每组30只。脓毒症模型通过尾静脉注射LPS(10 mg/kg)建立;白藜芦醇组于LPS注射后腹腔注射白藜芦醇(8 mg×kg-1×d-1),每日一次,连续2天。24小时后Morris水迷宫评估认知功能,检测脑含水量、Evans蓝渗漏及皮层MMP-9、Occludin、Claudin-5蛋白表达。结果显示白藜芦醇缩短逃避潜伏期、降低血脑屏障通透性、下调MMP-9并上调Occludin和Claudin-5,减少MMP-9与星形胶质细胞共定位。结论提示白藜芦醇可能通过抑制星形胶质细胞MMP-9改善SAE认知障碍,但为动物实验,临床转化需进一步验证。

要点

  • 脓毒症组较假手术组48小时逃避潜伏期延长(56.56±6.43 s vs. 36.62±3.32 s,P<0.01),72小时延长(57.72±7.23 s vs. 26.46±4.24 s,P<0.01)。
  • 白藜芦醇组较脓毒症组48小时逃避潜伏期缩短(41.42±6.27 s vs. 56.56±6.43 s,P<0.01),72小时缩短(33.46±7.17 s vs. 57.72±7.23 s,P<0.01)。
  • 白藜芦醇组脑含水量低于脓毒症组[(77.15±2.27)% vs.(84.56±2.03)%,P<0.01],Evans蓝渗漏减少[(7.74±1.88)μg/g vs.(17.56±2.28)μg/g,P<0.01]。
  • 白藜芦醇组皮层MMP-9蛋白表达低于脓毒症组(MMP-9/β-actin:0.25±0.01 vs. 0.73±0.01,P<0.01)。
  • 白藜芦醇组Occludin和Claudin-5蛋白表达高于脓毒症组(Occludin/β-actin:0.82±0.03 vs. 0.45±0.02;Claudin-5/β-actin:0.92±0.04 vs. 0.62±0.03,均P<0.01)。

适用人群与场景

  • 12周龄雄性Sprague-dawley(SD)大鼠,用于脓毒症相关脑病(SAE)模型研究;非人类临床人群。

诊断标准与关键阈值

  • 原文未提及

处置流程与药物剂量

  • 脓毒症模型建立:尾静脉注射LPS(10 mg/kg)。
  • 白藜芦醇干预:LPS注射后腹腔注射白藜芦醇(8 mg×kg-1×d-1),每日一次,连续2天;对照给予等量生理盐水。
  • 认知功能评估:模型建立后24小时行Morris水迷宫测试。

红旗征与不能漏的情况

  • 原文未提及

研究设计与关键结果

  • 干预与对照:白藜芦醇组腹腔注射白藜芦醇(8 mg×kg-1×d-1,每日一次,连续2天)vs. 脓毒症组等量生理盐水;假手术组等量生理盐水。
  • 主要终点:白藜芦醇组较脓毒症组48小时逃避潜伏期缩短(41.42±6.27 s vs. 56.56±6.43 s,P<0.01),72小时缩短(33.46±7.17 s vs. 57.72±7.23 s,P<0.01)。
  • 血脑屏障通透性:白藜芦醇组脑含水量低于脓毒症组[(77.15±2.27)% vs.(84.56±2.03)%,P<0.01],Evans蓝渗漏减少[(7.74±1.88)μg/g vs.(17.56±2.28)μg/g,P<0.01]。
  • 蛋白表达:白藜芦醇组皮层MMP-9低于脓毒症组(0.25±0.01 vs. 0.73±0.01,P<0.01),Occludin高于脓毒症组(0.82±0.03 vs. 0.45±0.02,P<0.01),Claudin-5高于脓毒症组(0.92±0.04 vs. 0.62±0.03,P<0.01)。
  • 共定位:白藜芦醇组MMP-9与星形胶质细胞GFAP共定位荧光强度低于脓毒症组(19.44±4.37 AU vs. 38.66±4.26 AU,P<0.01),MMP-9阳性细胞比例降低[(13.11±1.29)% vs.(26.92±1.77)%,P<0.01]。
  • 不良事件:原文未提及。

证据类型、等级与局限

  • 证据类型:动物实验(大鼠模型)。
  • 推荐强度或证据等级:原文未提及。
  • 局限:动物实验,样本量有限(每组30只),仅雄性大鼠,白藜芦醇给药方案为特定实验条件,临床转化需进一步验证。

对床旁实践的改变

  • 该动物实验提示白藜芦醇可能通过抑制星形胶质细胞MMP-9、保护紧密连接蛋白改善SAE认知障碍,但尚未在临床人群中验证,不能直接改变急诊/ICU对SAE的诊疗实践。
  • 适用人群:仅限实验动物研究;不适用于临床患者。
  • 常见陷阱:不能将动物实验中的白藜芦醇剂量(8 mg×kg-1×d-1腹腔注射)直接外推为临床推荐剂量;需等待临床试验证据。

指南或共识出处

  • 原文未提及

以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。

英文原文(摘要)· 点击展开

OBJECTIVE: To explore the mechanism of resveratrol on ameliorating the cognitive dysfunction induced by sepsis associated encephalopathy (SAE) in rats.

METHODS: The 12 weeks old male Sprague-dawley (SD) male rats were randomly divided into sham group, sepsis group and resveratrol group, with 30 rats in each group. The rat model of sepsis was made by injecting LPS (10 mg/kg) into tail vein. The rats in sham group was given the same amount of normal saline (NS). After LPS injection, resveratrol (8 mg×kg-1×d-1) was intraperitoneally injected once daily for 2 days in the resveratrol group; the same amount of NS was given to the sepsis group and sham group. At 24 hours after model establishment, the cognitive function of the experimental rats was assessed by the Morris water maze test. The blood-brain barrier (BBB) permeability was evaluated by the brain water content (BWC) and Evans blue (EB) test. The protein expressions of matrix metalloproteinase 9 (MMP-9), Occludin and Claudin-5 in cortical tissue were detected by Western Blot. Double immunofluorescence was used to verify the co-localization of MMP-9 protein and the marker protein of astrocyte GFAP in the cortical tissue of rats.

RESULTS: Compared with the sham group, the escape latency in the sepsis group was significantly longer [48-hour escape latency (s): 56.56±6.43 vs. 36.62±3.32, 72-hour escape latency (s): 57.72±7.23 vs. 26.46±4.24, both P < 0.01], the BWC and extravasation of EB were increased [BWC: (84.56±2.03)% vs. (76.82±2.22)%, EB (μg/g): 17.56±2.28 vs. 6.25±1.36, both P < 0.01], the expression of MMP-9 protein was increased (MMP-9/β-actin: 0.73±0.01 vs. 0.24±0.01, P < 0.01), the protein expressions of Occludin and Claudin-5 were decreased (Occludin/β-actin: 0.45±0.02 vs. 0.86±0.04, Claudin-5/β-actin: 0.62±0.03 vs. 0.96±0.05, both P < 0.01). At the same time, the co-localization expression of MMP-9 protein and the astrocytes of the cortical were increased [MMP-9 fluorescence intensity (AU): 38.66±4.26 vs. 17.23±3.04, MMP-9 positive cells: (26.92±1.77)% vs. (12.82±1.46)%, both P < 0.01]. Compared with the sepsis group, the escape latency in resveratrol group was significantly shorter [48-hour escape latency (s): 41.42±6.27 vs. 56.56±6.43, 72-hour escape latency (s): 33.46±7.17 vs. 57.72±7.23, both P < 0.01], the BWC and extravasation of EB were decreased [BWC: (77.15±2.27)% vs. (84.56±2.03)%, EB (μg/g): 7.74±1.88 vs. 17.56±2.28, both P < 0.01], the expression of MMP-9 protein was decreased (MMP-9/β-actin: 0.25±0.01 vs. 0.73±0.01, P < 0.01), the protein expressions of Occludin and Claudin-5 were increased (Occludin/β-actin: 0.82±0.03 vs. 0.45±0.02, Claudin-5/β-actin: 0.92±0.04 vs. 0.62±0.03, both P < 0.01). At the same time, the co-localization expression of MMP-9 protein and the astrocytes of the cortical were decreased [MMP-9 fluorescence intensity (AU): 19.44±4.37 vs. 38.66±4.26, MMP-9 positive cells: (13.11±1.29)% vs. (26.92±1.77)%, both P < 0.01].

CONCLUSIONS: Resveratrol can inhibit the expression of MMP-9 protein in the astrocytes of the cortical cortex of rats, and then reduce the degradation of tight junction proteins of Occludin and Claudin-5, thereby reducing BBB permeability and eventually ameliorate the cognitive dysfunction induced by SAE.

来源:Zhonghua Wei Zhong Bing Ji Jiu Yi Xue,查看原文。版权归原作者所有。

参考来源

  1. Liu X, Wen M, Han Y, et al. [Mechanism of resveratrol on ameliorating the cognitive dysfunction induced by sepsis associated encephalopathy in rats]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2020. PMID: 33198861. doi:10.3760/cma.j.cn121430-20200720-00531

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。